By Colin Kellaher
Dentsply Sirona said it won't reinstate at-home sales of its Byte dental aligner systems and impression kits, opting to refocus the Byte business model around treatments that include expanded in-person dentist oversight.
Dentsply, which in October suspended sales and marketing of the Byte products while it conducted a review of certain regulatory requirements, on Tuesday said it expects the move to result in potentially material impacts on its fourth-quarter results, including an estimate for customer refunds and possible asset write-offs.
Dentsply in October had warned that the decision to suspend Byte sales, which it made in consultation with the Food and Drug Administration, would have a material impact on its results, as sales of the products represent roughly 5% of its annual revenue.
The Charlotte, N.C., company on Tuesday said it will provide more information on the refunds and write-offs during its fourth-quarter earnings call.
Dentsply also said it will continue to provide support for non-contraindicated Byte aligner patients currently undergoing treatment.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
January 14, 2025 08:51 ET (13:51 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.